Compound 60 has an extremely high affinity to MDM2 (Ki < 1 nM), strong cellular activity, and an excellent oral pharmacokinetic profile. Compound sixty is capable of attaining complete and very long-Long lasting tumor regression in vivo and is at present in period I clinical trials for cancer remedy. if https://marcoglqtw.daneblogger.com/31299625/the-fact-about-squalene-that-no-one-is-suggesting